SARS2/COVID 19 in Middlesex County, Massachusetts: A Pilot Community Report
Main Article Content
Abstract
The rapid spread, and relentless mutations of SARS2, are a reminder of how quickly upper respiratory viruses that do not cause acute, debilitating disease in all infected persons can spread, and that continuing mutation is an adaptive hallmark of viruses. The global response to the SARS2/COVID19 pandemic varied widely, country to country, and state to state in the United States of America (U.S.). To better prepare for the next pandemic, the U.S. Government Accounting Office recommends that health agencies “…identify, document and share all challenges and lessons learned … to improve the response to ongoing and future public health emergencies…” Some countries continually published SARS2/ COVID19 reviews and adjusted recommendations throughout the pandemic, but an objective review of the U.S. SARS2/COVID19 public health response is lacking. This knowledge gap can be at least partially filled by taking advantage of publicly-available databases. As an example, this is a report of the spread of SARS2/COVID19 in diverse communities in Middlesex County, Massachusetts. Neither mask mandates nor vaccinations halted the surge of SARS2/COVID19 in January, 2022; communities with the highest infection incidence were statistically significantly lowest in per capita income and highest in population density. If these findings apply globally, the development of a library of effective medications should be the first-line defense against the next pandemic, with a plan for effective distribution to the most vulnerable persons.
Keywords:
SARS2/COVID-19, Public health response, Middlesex County, Massachusetts, Community health report, Infection incidence, Socioeconomic factors, Pandemic preparedness
Article Details
How to Cite
KIESSLING, Ann A.
SARS2/COVID 19 in Middlesex County, Massachusetts: A Pilot Community Report.
Medical Research Archives, [S.l.], v. 12, n. 8, aug. 2024.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/5613>. Date accessed: 22 nov. 2024.
doi: https://doi.org/10.18103/mra.v12i8.5613.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Wu S, Yao M, Deng C, et al. Social Isolation and Anxiety Disorder During the COVID-19 Pandemic and Lockdown in China. J Affect Disord. Nov 1 2021;294:10-16. doi: 10.1016/j.jad.2021.06.067.
2. Norberg, Johan. “Sweden during the Pandemic: Pariah or Paragon?,” Policy Analysis no. 959, CATO Institute, August 29, 2023.
3. Sott M , Bender M, Baum K. Covid-19 outbreak in Brazil: health, social, political and economic implications. Int’l J of Health Services. 2022; (52)4: 1-13. DOI: 10.1177/00207314221122658.
4. Qualls N, Levitt A, Kanade N, et al. CDC Community Mitigation Guidelines Work Group. Community Mitigation Guidelines to Prevent Pandemic Influenza – United States. MMWR Recomm Rep. 2017 Apr 21;66(1):1-34. doi: 10.15585/mmwr.rr6601a1.
4a. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. https://www.cdc.gov/coronavirus/2019-ncov/covid-19-data-and-surveillance.html
5. Shuren, J. Coronavirus (COVID-19) Update: FDA issues new policy to help expedite availability of diagnostics. Feb 29, 2020. https://wayback.archive-it.org/7993/20201217234232/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics
6. Kulldorff M, Gupta S, Battacharya J. Great Barrington Declaration, Focused Protection. Oct 4, 2020. https://gbdeclaration.org/.
7. Editorial Board. How Fauci and Collins shut down COVID debate. Wall Street Journal, Dec 21, 2021. https://www.wsj.com/articles/fauci-collins-emails-great-barrington-declaration-covid-pandemic-lockdown-11640129116
8. Prasad V. At a time when the U.S. needed COVID-19 dialogue between scientist, Francis Collins moved to shut it down. STAT Dec 29, 2022 https://www.statnews.com/2021/12/23/at-a-time-when-the-u-s-needed-covid-19-dialogue-between-scientists-francis-collins-moved-to-shut-it-down/
9. ABC News. Fauci calls ‘herd immunity’ declaration embraced by White House ‘ridiculous.” Oct 15, 2020. https://abcnews.go.com/Health/live-updates/coronavirus/fauci-calls-herd-immunity-declaration-embraced-by-white-house-ridiculous-73627869?id=73623859
10. California Department of Public Health. https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/COVID-19-Isolation-Guidance.aspx.
11. Florida Department of Public Health. https://www.floridahealth.gov/diseases-and-conditions/respiratory-illness/COVID-19/index.html
12. Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: "Vaccination Refusal Could Prolong the War of This Pandemic" - A Systematic Review. Risk Manag Health Policy. 2021 Jun 21;14:2609-2623. doi: 10.2147/RMHP.S311074.
13. Osamor VC, Ikeakanam E, Bishung JU, et al. COVID-19 Vaccines: Computational tools and Development. Inform Med Unlocked. 2023;37:1 01164. doi: 10.1016/j.imu.2023.101164.
14. Choi J. Fauci: Vaccinated people become ‘dead ends’ for the coronavirus. The Hill May 16, 2021. https://thehill.com/homenews/sunday-talk-shows/553773-fauci-vaccinated-people-become-dead-ends-for-the-coronavirus/.
15. United States Government Accountability Office. COVID-19: GAO recommendations can help federal agencies better prepare for future public health emergencies. GAO COVID19 Eval, July, 2023: GAO -23- 106554. https://www.gao.gov/coronavirus
16. Mauzy S, Putney K, Baroni E, et al. Lessons Learned: The Varied Responses of Massachusetts' Local Health Departments During the COVID-19 Pandemic. J Public Health Manag Pract. 2022 Jul-Aug 01;28(4):344-352. doi: 10.1097/PHH.0000000 000001547.
17. Division of Local Services, MA Department of Revenue, 2024 posting. https://dlsgateway.dor.state.ma.us/reports/rdPage.aspx?rdReport=Community_Comparison_Report
18. Allen E, Hohler B and Swidey N. The virus’s tale. Boston Globe May 30, 2020. https://apps.bostonglobe.com/metro/graphics/2020/05/coronavirus-tale/
19. Fatima S. These are all the Massachusetts towns that have indoor mask mandates. The Boston Globe, December 14, 2021. https://www.bostonglobe.com/2021/12/15/nation/these-are-all-massachusetts-towns-that-have-indoor-mask-mandates/
20. Massachusetts Department of Public Health Coronavirus Disease 2019.
https://www.mass.gov/coronavirus-disease-2019-covid-19
21. Soares-Weiser K. Statement on physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane, June, 2024. https://www.cochrane.org/news/statement-physical-interventions-interrupt-or-reduce-spread-respiratory-viruses-review
22. Lazzarino A. The curious case of the Danish Mask study. British Medical Journal;371:m4586. doi: https://doi.org/10.1136/bmj.m4586
23. Frota S, Esteve-Gibert N, Molnar M, Vigário M. Editorial: Language development behind the mask. Front Psychol. 2023 May 3;14:1205215. doi: 10.3389/fpsyg.2023.1205215.
24. Abaluck J, Kwong LH, Styczynski A, et al. Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh. Science. 2022 Jan 14;375(6577):eabi9069. doi: 10.1126/ science.abi9069.
25. Frutos A. Interim estimates of 2023-2024 seasonal influenza vaccine effectiveness – United States. Weekly: February 29, 2024; 73(8), 168-174. https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a3.htm
26. Branswell H. The vaccine dilemma: how experts weigh benefits for many against risks for a few. STAT, April 23, 2018. https://www.statnews.com/2018/04/23/vaccine-dilemma-weigh-benefits-risks/?matchtype=&keyword=&cid=20740002454&agid=&device=c&placement=&creative=&target=&adposition=&utm_source=google&utm_medium=cpc&utm_campaign=pmax-health-tech&utm_term=&utm_content=&hsa_acc=5862992171&hsa_cam=20740002454&hsa_grp=&hsa_ad=&hsa_src=x&hsa_tgt=&hsa_kw=&hsa_mt=&hsa_net=adwords&hsa_ver=3&gad_source=1&gclid=EAIaIQobChMI26f1p5eVhwMVgkH_AR2QhAhnEAMYASAAEgIhzfD_BwE
27. Lind ML, Dorion M, Houde AJ, et al. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population. Nat Commun. 2023 Aug 19;14(1):5055. doi: 10.1038/s41467-023-40750-8.
28. Martinez MA. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00399-20. doi: 10.1128/AAC.00399-20.
29. Redfield, R, U. S. Senate Committee on Homeland Security and Government Affairs “Risky Research: Oversight of U.S. taxpayer funded high-risk research” July 11, 2024. https://www.hsgac.senate.gov/hearings/risky-research-oversight-of-u-s-taxpayer-funded-high-risk-virus-research/.
30. Rancourt DG, Hickey J Linard C., “Spatiotemporal variation of excess all-cause mortality in the world (125 countries) during the Covid period 2020-2023 regarding socio economic factors and public-health and medical interventions”, Correlation Report. July 19, 2024.
31. Hallett DBE. Module 1: The Resilience and Preparedness of the United Kingdom. UK COVID 19 Inquiry. July, 2024 https://covid19.public-inquiry.uk/wp-content/uploads/2024/07/18095012/UK-Covid-19-Inquiry-Module-1-Full-Report.pdf.
2. Norberg, Johan. “Sweden during the Pandemic: Pariah or Paragon?,” Policy Analysis no. 959, CATO Institute, August 29, 2023.
3. Sott M , Bender M, Baum K. Covid-19 outbreak in Brazil: health, social, political and economic implications. Int’l J of Health Services. 2022; (52)4: 1-13. DOI: 10.1177/00207314221122658.
4. Qualls N, Levitt A, Kanade N, et al. CDC Community Mitigation Guidelines Work Group. Community Mitigation Guidelines to Prevent Pandemic Influenza – United States. MMWR Recomm Rep. 2017 Apr 21;66(1):1-34. doi: 10.15585/mmwr.rr6601a1.
4a. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. https://www.cdc.gov/coronavirus/2019-ncov/covid-19-data-and-surveillance.html
5. Shuren, J. Coronavirus (COVID-19) Update: FDA issues new policy to help expedite availability of diagnostics. Feb 29, 2020. https://wayback.archive-it.org/7993/20201217234232/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics
6. Kulldorff M, Gupta S, Battacharya J. Great Barrington Declaration, Focused Protection. Oct 4, 2020. https://gbdeclaration.org/.
7. Editorial Board. How Fauci and Collins shut down COVID debate. Wall Street Journal, Dec 21, 2021. https://www.wsj.com/articles/fauci-collins-emails-great-barrington-declaration-covid-pandemic-lockdown-11640129116
8. Prasad V. At a time when the U.S. needed COVID-19 dialogue between scientist, Francis Collins moved to shut it down. STAT Dec 29, 2022 https://www.statnews.com/2021/12/23/at-a-time-when-the-u-s-needed-covid-19-dialogue-between-scientists-francis-collins-moved-to-shut-it-down/
9. ABC News. Fauci calls ‘herd immunity’ declaration embraced by White House ‘ridiculous.” Oct 15, 2020. https://abcnews.go.com/Health/live-updates/coronavirus/fauci-calls-herd-immunity-declaration-embraced-by-white-house-ridiculous-73627869?id=73623859
10. California Department of Public Health. https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/COVID-19-Isolation-Guidance.aspx.
11. Florida Department of Public Health. https://www.floridahealth.gov/diseases-and-conditions/respiratory-illness/COVID-19/index.html
12. Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: "Vaccination Refusal Could Prolong the War of This Pandemic" - A Systematic Review. Risk Manag Health Policy. 2021 Jun 21;14:2609-2623. doi: 10.2147/RMHP.S311074.
13. Osamor VC, Ikeakanam E, Bishung JU, et al. COVID-19 Vaccines: Computational tools and Development. Inform Med Unlocked. 2023;37:1 01164. doi: 10.1016/j.imu.2023.101164.
14. Choi J. Fauci: Vaccinated people become ‘dead ends’ for the coronavirus. The Hill May 16, 2021. https://thehill.com/homenews/sunday-talk-shows/553773-fauci-vaccinated-people-become-dead-ends-for-the-coronavirus/.
15. United States Government Accountability Office. COVID-19: GAO recommendations can help federal agencies better prepare for future public health emergencies. GAO COVID19 Eval, July, 2023: GAO -23- 106554. https://www.gao.gov/coronavirus
16. Mauzy S, Putney K, Baroni E, et al. Lessons Learned: The Varied Responses of Massachusetts' Local Health Departments During the COVID-19 Pandemic. J Public Health Manag Pract. 2022 Jul-Aug 01;28(4):344-352. doi: 10.1097/PHH.0000000 000001547.
17. Division of Local Services, MA Department of Revenue, 2024 posting. https://dlsgateway.dor.state.ma.us/reports/rdPage.aspx?rdReport=Community_Comparison_Report
18. Allen E, Hohler B and Swidey N. The virus’s tale. Boston Globe May 30, 2020. https://apps.bostonglobe.com/metro/graphics/2020/05/coronavirus-tale/
19. Fatima S. These are all the Massachusetts towns that have indoor mask mandates. The Boston Globe, December 14, 2021. https://www.bostonglobe.com/2021/12/15/nation/these-are-all-massachusetts-towns-that-have-indoor-mask-mandates/
20. Massachusetts Department of Public Health Coronavirus Disease 2019.
https://www.mass.gov/coronavirus-disease-2019-covid-19
21. Soares-Weiser K. Statement on physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane, June, 2024. https://www.cochrane.org/news/statement-physical-interventions-interrupt-or-reduce-spread-respiratory-viruses-review
22. Lazzarino A. The curious case of the Danish Mask study. British Medical Journal;371:m4586. doi: https://doi.org/10.1136/bmj.m4586
23. Frota S, Esteve-Gibert N, Molnar M, Vigário M. Editorial: Language development behind the mask. Front Psychol. 2023 May 3;14:1205215. doi: 10.3389/fpsyg.2023.1205215.
24. Abaluck J, Kwong LH, Styczynski A, et al. Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh. Science. 2022 Jan 14;375(6577):eabi9069. doi: 10.1126/ science.abi9069.
25. Frutos A. Interim estimates of 2023-2024 seasonal influenza vaccine effectiveness – United States. Weekly: February 29, 2024; 73(8), 168-174. https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a3.htm
26. Branswell H. The vaccine dilemma: how experts weigh benefits for many against risks for a few. STAT, April 23, 2018. https://www.statnews.com/2018/04/23/vaccine-dilemma-weigh-benefits-risks/?matchtype=&keyword=&cid=20740002454&agid=&device=c&placement=&creative=&target=&adposition=&utm_source=google&utm_medium=cpc&utm_campaign=pmax-health-tech&utm_term=&utm_content=&hsa_acc=5862992171&hsa_cam=20740002454&hsa_grp=&hsa_ad=&hsa_src=x&hsa_tgt=&hsa_kw=&hsa_mt=&hsa_net=adwords&hsa_ver=3&gad_source=1&gclid=EAIaIQobChMI26f1p5eVhwMVgkH_AR2QhAhnEAMYASAAEgIhzfD_BwE
27. Lind ML, Dorion M, Houde AJ, et al. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population. Nat Commun. 2023 Aug 19;14(1):5055. doi: 10.1038/s41467-023-40750-8.
28. Martinez MA. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00399-20. doi: 10.1128/AAC.00399-20.
29. Redfield, R, U. S. Senate Committee on Homeland Security and Government Affairs “Risky Research: Oversight of U.S. taxpayer funded high-risk research” July 11, 2024. https://www.hsgac.senate.gov/hearings/risky-research-oversight-of-u-s-taxpayer-funded-high-risk-virus-research/.
30. Rancourt DG, Hickey J Linard C., “Spatiotemporal variation of excess all-cause mortality in the world (125 countries) during the Covid period 2020-2023 regarding socio economic factors and public-health and medical interventions”, Correlation Report. July 19, 2024.
31. Hallett DBE. Module 1: The Resilience and Preparedness of the United Kingdom. UK COVID 19 Inquiry. July, 2024 https://covid19.public-inquiry.uk/wp-content/uploads/2024/07/18095012/UK-Covid-19-Inquiry-Module-1-Full-Report.pdf.